43 related articles for article (PubMed ID: 2801679)
1. A new technique for segmental jejunal perfusion in man.
Knutson L; Odlind B; Hällgren R
Am J Gastroenterol; 1989 Oct; 84(10):1278-84. PubMed ID: 2801679
[TBL] [Abstract][Full Text] [Related]
2. Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption.
Arnold YE; Thorens J; Bernard S; Kalia YN
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30901927
[TBL] [Abstract][Full Text] [Related]
3. Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.
Olivares-Morales A; Lennernäs H; Aarons L; Rostami-Hodjegan A
AAPS J; 2015 Sep; 17(5):1177-92. PubMed ID: 25986421
[TBL] [Abstract][Full Text] [Related]
4. Population-based mechanistic prediction of oral drug absorption.
Jamei M; Turner D; Yang J; Neuhoff S; Polak S; Rostami-Hodjegan A; Tucker G
AAPS J; 2009 Jun; 11(2):225-37. PubMed ID: 19381840
[TBL] [Abstract][Full Text] [Related]
5. The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis.
Hvatum M; Kanerud L; Hällgren R; Brandtzaeg P
Gut; 2006 Sep; 55(9):1240-7. PubMed ID: 16484508
[TBL] [Abstract][Full Text] [Related]
6. A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine.
Persson EM; Nilsson RG; Hansson GI; Löfgren LJ; Libäck F; Knutson L; Abrahamsson B; Lennernäs H
Pharm Res; 2006 Apr; 23(4):742-51. PubMed ID: 16482422
[TBL] [Abstract][Full Text] [Related]
7. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids.
Persson EM; Gustafsson AS; Carlsson AS; Nilsson RG; Knutson L; Forsell P; Hanisch G; Lennernäs H; Abrahamsson B
Pharm Res; 2005 Dec; 22(12):2141-51. PubMed ID: 16247711
[TBL] [Abstract][Full Text] [Related]
8. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R
Gut; 2004 Dec; 53(12):1806-12. PubMed ID: 15542519
[TBL] [Abstract][Full Text] [Related]
9. Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.
Wilding IR; Connor AL; Carpenter P; Rordorf C; Branson J; Milosavljev S; Scott G
Pharm Res; 2004 Mar; 21(3):443-6. PubMed ID: 15070094
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers.
Tavelin S; Taipalensuu J; Söderberg L; Morrison R; Chong S; Artursson P
Pharm Res; 2003 Mar; 20(3):397-405. PubMed ID: 12669959
[TBL] [Abstract][Full Text] [Related]
11. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.
Tannergren C; Knutson T; Knutson L; Lennernäs H
Br J Clin Pharmacol; 2003 Feb; 55(2):182-90. PubMed ID: 12580990
[TBL] [Abstract][Full Text] [Related]
12. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis.
Taha Y; Carlson M; Thorn M; Loof L; Raab Y
Dig Dis Sci; 2001 Apr; 46(4):888-97. PubMed ID: 11330429
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?
Blume HH; Schug BS
Eur J Drug Metab Pharmacokinet; 2000; 25(1):41-8. PubMed ID: 11032090
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.
Santos J; Bayarri C; Saperas E; Nogueiras C; Antolín M; Mourelle M; Cadahia A; Malagelada JR
Gut; 1999 Oct; 45(4):553-8. PubMed ID: 10486364
[TBL] [Abstract][Full Text] [Related]
15. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.
Sandström R; Knutson TW; Knutson L; Jansson B; Lennernäs H
Br J Clin Pharmacol; 1999 Aug; 48(2):180-9. PubMed ID: 10417494
[TBL] [Abstract][Full Text] [Related]
16. Jejunal absorption and metabolism of R/S-verapamil in humans.
Sandström R; Karlsson A; Knutson L; Lennernäs H
Pharm Res; 1998 Jun; 15(6):856-62. PubMed ID: 9647350
[TBL] [Abstract][Full Text] [Related]
17. Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.
Mäki-Ikola O; Hällgren R; Kanerud L; Feltelius N; Knutsson L; Granfors K
Ann Rheum Dis; 1997 Jul; 56(7):421-5. PubMed ID: 9486004
[TBL] [Abstract][Full Text] [Related]
18. Characterization of fluids from the stomach and proximal jejunum in men and women.
Lindahl A; Ungell AL; Knutson L; Lennernäs H
Pharm Res; 1997 Apr; 14(4):497-502. PubMed ID: 9144738
[TBL] [Abstract][Full Text] [Related]
19. Absorption profiles for polyethylene glycols after regional jejunal perfusion and oral load in healthy humans.
Söderholm JD; Olaison G; Kald A; Tagesson C; Sjödahl R
Dig Dis Sci; 1997 Apr; 42(4):853-7. PubMed ID: 9125661
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.
Lennernäs H; Nilsson D; Aquilonius SM; Ahrenstedt O; Knutson L; Paalzow LK
Br J Clin Pharmacol; 1993 Mar; 35(3):243-50. PubMed ID: 8471400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
